{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Intensity Therapeutics, Inc.
Is Intensity Therapeutics, Inc. technically bullish or bearish?
As of April 23, 2025, the technical trend has shifted to bearish, supported by bearish MACD signals, moving averages, and Bollinger Bands, despite a bullish OBV on the monthly chart.
What does Intensity Therapeutics, Inc. do?
Intensity Therapeutics, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $3 million and a market cap of $4.32 million. Key financial metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -1,501.20%.
How big is Intensity Therapeutics, Inc.?
As of Jun 18, Intensity Therapeutics, Inc. has a market capitalization of 4.32 million, with net sales of 0.00 million and a net profit of -15.01 million over the last four quarters. The company's shareholder's funds are 2.92 million, and total assets are 4.78 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
